Neuroscientist Dr Andrew Huberman: The Moment That GLP1s Hit The Compounding Pharmacy Market, The Wellness Community Changed Their Tune
Stanford neuroscientist Dr. Andrew Huberman has observed a shift in how the wellness community discusses weight loss treatments, particularly GLP-1 agonists like Ozempic and Wegovy. During a recent podcast appearance, Huberman…



















